Generate a tailored SOP for Dr. Per Anders Jansson. Improve your application with a focused, well-structured draft.
Per-Anders Jansson is a Professor and Chief Physician at the University of Gothenburg, specializing in Translational Medical Research. He is board certified in General Internal Medicine and has held various roles, including a Clinical Researcher position funded by the Swedish Research Council. His research primarily focuses on the mechanisms of insulin resistance and its implications for prediabetes and type 2 diabetes. He leads the IRVASC project, which examines how the vascular system affects insulin distribution in the body. The aim is to uncover new strategies to prevent and treat type 2 diabetes, a condition affecting millions globally. Jansson has contributed significantly to the scientific community with numerous publications detailing his findings on glucose metabolism and vascular insulin response. Additionally, he collaborates with a multidisciplinary team to investigate the role of microvascular changes in patients with insulin resistance, striving to identify factors that contribute to the development of type 2 diabetes and improve patient outcomes.
University of Gothenburg • Gothenburg, Sweden
Leading research in Translational Medical Research with a focus on insulin resistance and type 2 diabetes.
Sahlgrenska University Hospital • Gothenburg, Sweden
Providing clinical expertise and leading research initiatives at the hospital.
Administered by the Department of Political Science; focus on International Administration and Global Governance (IAGG).